KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Other financing activities (2016 - 2026)

Edwards Lifesciences has reported Other financing activities over the past 17 years, most recently at -$3.1 million for Q4 2025.

  • For Q4 2025, Other financing activities fell 3200.0% year-over-year to -$3.1 million; the TTM value through Dec 2025 reached -$3.8 million, down 22.58%, while the annual FY2025 figure was -$3.8 million, 22.58% down from the prior year.
  • Other financing activities for Q4 2025 was -$3.1 million at Edwards Lifesciences, down from -$2.4 million in the prior quarter.
  • Over five years, Other financing activities peaked at $7.2 million in Q2 2024 and troughed at -$10.2 million in Q3 2024.
  • A 5-year average of -$647368.4 and a median of -$100000.0 in 2021 define the central range for Other financing activities.
  • Biggest five-year swings in Other financing activities: skyrocketed 1900.0% in 2023 and later plummeted 3200.0% in 2025.
  • Year by year, Other financing activities stood at $700000.0 in 2021, then plummeted by 85.71% to $100000.0 in 2022, then skyrocketed by 1900.0% to $2.0 million in 2023, then tumbled by 95.0% to $100000.0 in 2024, then plummeted by 3200.0% to -$3.1 million in 2025.
  • Business Quant data shows Other financing activities for EW at -$3.1 million in Q4 2025, -$2.4 million in Q3 2025, and $1.0 million in Q2 2025.